Gynecologic Cancer
Latest News
Renewed calls for fallopian tube removal to avoid ovarian cancer
There is increasing evidence that most high-grade serous ovarian cancers arise from cells in the fallopian tubes.
Opinion
Update on secondary cytoreduction in recurrent ovarian cancer
Secondary debulking surgery has been studied since the 1980s with mixed results; these data have shown that the largest barrier to care has been...
Feature
3D-printed tumor models could advance new cancer therapies
The impact could be “huge,” says Y. Shrike Zhang, PhD, of Harvard Medical School.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
Latest News
Cervical cancer in women 65+ often deadly: so why not screen?
Older patients, even those with early disease, had much poorer survival after they were diagnosed with cervical cancer than their younger...
Diminutio
Oncologists may be too quick to refer patients to palliative care
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
Feature
Cancer clinics begin to accommodate patients demanding new cancer detection tests
Sales teams are making a big push for multicancer early detection tests.
Latest News
Cervical cancer rise in White women: A ‘canary in the coal mine’
“If rising incidence is not for localized-stage disease, but for advanced stages, that means it’s attributable to lack of screening.”
Perspectives
Diagnosed too late
We take a course in giving bad news, but every doctor has his or her own approach.
News
FDA requests more restrictions on ovarian cancer drugs
Several companies have already withdrawn their respective PARP inhibitors for heavily pretreated patients with ovarian cancer.
Commentary
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.